Dafna Capital Management LLC Infla Rx N.V. Transaction History
Dafna Capital Management LLC
- $344 Million
- Q2 2025
A detailed history of Dafna Capital Management LLC transactions in Infla Rx N.V. stock. As of the latest transaction made, Dafna Capital Management LLC holds 200,000 shares of IFRX stock, worth $314,000. This represents 0.05% of its overall portfolio holdings.
Number of Shares
200,000
Previous 450,000
55.56%
Holding current value
$314,000
Previous $459,000
65.58%
% of portfolio
0.05%
Previous 0.14%
Shares
4 transactions
Others Institutions Holding IFRX
# of Institutions
31Shares Held
17.5MCall Options Held
32.7KPut Options Held
0-
Suvretta Capital Management, LLC New York, NY6.48MShares$10.2 Million0.18% of portfolio
-
683 Capital Management, LLC New York, NY2.48MShares$3.89 Million0.15% of portfolio
-
Ra Capital Management, L.P. Boston, MA1.97MShares$3.1 Million0.03% of portfolio
-
Eversept Partners, LP New York, NY1.64MShares$2.58 Million0.13% of portfolio
-
Woodline Partners LP San Francisco, CA751KShares$1.18 Million0.0% of portfolio
About InflaRx N.V.
- Ticker IFRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,203,800
- Market Cap $69.4M
- Description
- InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...